Best Value Stocks For 2018

tags:BSRR,BPT,UUUU,AIMT,AEGN,

If�Vipshop Holdings (NYSE:VIPS)�investors are feeling jittery these days, it's because they know that earnings season is here. The Chinese online discounter of brand-name apparel reports its first-quarter results after the market close on Monday, and it's been known to treat longs and shorts to some pretty wild swings. Vipshop will host its earnings call on Tuesday morning ahead of the market open.

The dot-com speedster is expected to check in with another quarter of hearty double-digit percentage growth on the top line. Analysts see revenue rising 22.4% to $3.08 billion. It's a different story on the bottom line, where analysts see earnings per share declining to $0.18 after scoring a profit of $0.21 a year earlier.�

Image source: Vipshop Holdings.

Watch me move

Vipshop has had no shortage of ups and downs. The stock more than doubled for three consecutive years, from 2012 to 2014 -- something you rarely see -- only to lose nearly half its value in the two years that followed. The stock bounced back slightly in 2017. Vipshop has gone on to trounce the market averages in 2018, but it's now declining for the third month in a row.�

Best Value Stocks For 2018: Sierra Bancorp(BSRR)

Advisors' Opinion:

• [By Ethan Ryder]

  O Shaughnessy Asset Management LLC trimmed its position in Sierra Bancorp (NASDAQ:BSRR) by 41.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,173 shares of the financial services provider’s stock after selling 7,846 shares during the quarter. O Shaughnessy Asset Management LLC owned 0.07% of Sierra Bancorp worth $298,000 at the end of the most recent reporting period.

Best Value Stocks For 2018: BP Prudhoe Bay Royalty Trust(BPT)

Advisors' Opinion:

• [By Dan Caplinger]

  The stock market had a tumultuous session on Wednesday, as major benchmarks started the day weak but bounced back in the afternoon. Investors weren't happy with the current state of geopolitical uncertainty, with trade disputes threatening to become larger problems than ever. But the release of the minutes of the latest meeting of the Federal Reserve's monetary policy committee convinced many that the central bank will be slow to do lasting damage to the economic expansion, remaining measured in the pace of its interest rate increases. Moreover, some companies had good news that sent their shares higher. Tiffany (NYSE:TIF), BP Prudhoe Bay Royalty Trust (NYSE:BPT), and Ralph Lauren (NYSE:RL) were among the best performers on the day. Here's why they did so well.

• [By Joseph Griffin]

  News headlines about BP Prudhoe Bay Royalty Trust (NYSE:BPT) have been trending somewhat positive this week, Accern Sentiment reports. Accern identifies negative and positive news coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. BP Prudhoe Bay Royalty Trust earned a daily sentiment score of 0.09 on Accern’s scale. Accern also gave media headlines about the oil and gas company an impact score of 46.2072909143413 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Best Value Stocks For 2018: Energy Fuels Inc(UUUU)

Advisors' Opinion:

• [By Stephan Byrd]

  Energy Fuels (NYSEAMERICAN:UUUU) (TSE:EFR) shares saw an uptick in trading volume on Monday . 1,091,365 shares were traded during mid-day trading, an increase of 300% from the previous session’s volume of 272,846 shares.The stock last traded at $2.09 and had previously closed at $2.04.

Best Value Stocks For 2018: Aimmune Therapeutics, Inc.(AIMT)

Advisors' Opinion:

• [By ]

  In the Lightning Round, Cramer was bullish on Ingersoll-Rand (IR) , The Blackstone Group (BX) , Thermo Fisher Scientific (TMO) , FMC Corp (FMC) , Nike (NKE) , Zebra Technologies (ZBRA) and Aimmune Therapeutics (AIMT) .

• [By Chris Lange]

  Aimmune Therapeutics Inc. (NASDAQ: AIMT) is looking for Phase 3 data for in its Palisade trial of AR101 in February. Specifically, this trial is looking to treat peanut allergies. Shares closed trading most recently at $37.13, with a consensus price target of $55.50 and a 52-week range of $15.97 to $40.65.

• [By ]

  Aimmune Therapeutics (AIMT) : "I do like it. That's an important niche business. "

  Ingersoll-Rand (IR) : "I like Ingersoll-Rand. They work well at this phase in the cycle."

Best Value Stocks For 2018: Aegion Corp(AEGN)

Advisors' Opinion:

• [By Shane Hupp]

  LSV Asset Management decreased its position in Aegion Corp (NASDAQ:AEGN) by 5.7% in the 1st quarter, HoldingsChannel reports. The fund owned 108,700 shares of the construction company’s stock after selling 6,600 shares during the period. LSV Asset Management’s holdings in Aegion were worth $2,490,000 as of its most recent filing with the Securities & Exchange Commission.

• [By Stephan Byrd]

  Aegion (NASDAQ:AEGN) was upgraded by stock analysts at BidaskClub from a “hold” rating to a “buy” rating in a report issued on Wednesday.

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on Aegion (AEGN)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com